Save more lives by fueling the discovery and development
of powerful immunotherapies for all types of cancer.

Established in 1953, the Cancer Research Institute (CRI) is a nonprofit organization dedicated exclusively to harnessing the immune system's power to conquer all cancers. We fund the most innovative research by young scientists, invest in clinical studies of promising new treatments, and serve as a bridge between the lab and the clinic. CRI has invested $357 million to fund more than 3,100 scientists all over the world. With 65 years of experience funding research on the immune system and cancer, CRI is leading the way and ushering in a new era when patients with all types of cancer can be treated and cured with immunotherapy.